Axmed raises $2M from Founderful to streamline drug supply chains in underserved markets
- About 2 billion people lack access to quality and affordable essential medicines.
- Axmed raised $2 million in seed funding from Founderful Ventures.
- Axmed aims to fix supply chain fragmentation and connect manufacturers with health institutions.
Axmed's mission to address the lack of access to essential medicines in lower- and middle-income countries is commendable. By fixing supply chain fragmentation and connecting manufacturers with health institutions, they have the potential to improve the availability and affordability of medicines. The platform's focus on aggregating demand and engaging manufacturers effectively can create a sustainable and attractive market opportunity.
